LncRNA HOTAIR regulates HIF-1α/AXL signaling through inhibition of miR-217 in renal cell carcinoma
- PMID: 28492542
- PMCID: PMC5520706
- DOI: 10.1038/cddis.2017.181
LncRNA HOTAIR regulates HIF-1α/AXL signaling through inhibition of miR-217 in renal cell carcinoma
Retraction in
-
Retraction Note: LncRNA HOTAIR regulates HIF-1α/AXL signaling through inhibition of miR-217 in renal cell carcinoma.Cell Death Dis. 2024 Oct 1;15(10):716. doi: 10.1038/s41419-024-07111-9. Cell Death Dis. 2024. PMID: 39353884 Free PMC article. No abstract available.
Abstract
Long non-coding RNA HOTAIR was regarded as an oncogene in multiple cancers. Previous studies have shown that HOTAIR is involved in the proliferation and tumorigenesis of renal carcinoma cells, while microRNA (miR)-217 functions as a tumor suppressor in renal cell carcinoma (Rcc). However, the underlying molecular mechanism of HOTAIR in Rcc, especially in association with miR-217, has not been studied. In this study, we first demonstrated that HOTAIR expression was upregulated, which was correlated with tumor progression, and miR-217 downregulated in Rcc tissues and cells. Importantly, HOTAIR expression was negatively correlated with miR-217 expression in Rcc tissues. Gain- and loss-of-function of HOTAIR revealed that HOTAIR functioned as a ceRNA for miR-217 to facilitate HIF-1α expression and then upregulated AXL level promoting Rcc proliferation, migration, and EMT process, and inhibiting apoptosis. Furthermore, HOTAIR knockdown suppressed tumor growth and reduced the expression of proliferation antigen ki-67, HIF-1α, and AXL, but upregulated the expression of miR-217 in vivo. Finally, with AXL inhibitor BGB324, we confirmed that HOTAIR promoted Rcc activity through AXL signaling both in vitro and in vivo. In conclusion, these results suggest that HOTAIR promotes Rcc tumorigenesis via miR-217/HIF-1α/AXL signaling, which may provide a new target for the diagnosis and therapy of Rcc disease.
Conflict of interest statement
The authors declare no conflict of interest.
Figures





Similar articles
-
Long noncoding RNA H19 regulates HIF-1α/AXL signaling through inhibiting miR-20b-5p in endometrial cancer.Cell Cycle. 2019 Oct;18(19):2454-2464. doi: 10.1080/15384101.2019.1648958. Epub 2019 Aug 14. Cell Cycle. 2019. Retraction in: Cell Cycle. 2021 Dec;20(24):2663. doi: 10.1080/15384101.2021.1971875. PMID: 31411527 Free PMC article. Retracted.
-
Suppression of lncRNA HOTAIR alleviates RCC angiogenesis through regulating miR-126/EGFL7 axis.Am J Physiol Cell Physiol. 2021 May 1;320(5):C880-C891. doi: 10.1152/ajpcell.00459.2019. Epub 2021 Jan 27. Am J Physiol Cell Physiol. 2021. PMID: 33502949
-
LncRNA XIST modulates HIF-1A/AXL signaling pathway by inhibiting miR-93-5p in colorectal cancer.Mol Genet Genomic Med. 2020 Apr;8(4):e1112. doi: 10.1002/mgg3.1112. Epub 2020 Feb 15. Mol Genet Genomic Med. 2020. PMID: 32061057 Free PMC article.
-
Treatment of advanced renal cell carcinoma patients with cabozantinib, an oral multityrosine kinase inhibitor of MET, AXL and VEGF receptors.Future Oncol. 2019 Jul;15(20):2337-2348. doi: 10.2217/fon-2019-0021. Epub 2019 Jun 11. Future Oncol. 2019. PMID: 31184937 Review.
-
The molecular mechanism of NF-κB dysregulation across different subtypes of renal cell carcinoma.J Adv Res. 2025 Jun;72:501-514. doi: 10.1016/j.jare.2024.07.030. Epub 2024 Jul 31. J Adv Res. 2025. PMID: 39094893 Free PMC article. Review.
Cited by
-
Long noncoding RNA LINC00641 promotes renal cell carcinoma progression via sponging microRNA-340-5p.Cancer Cell Int. 2021 Apr 14;21(1):210. doi: 10.1186/s12935-021-01895-y. Cancer Cell Int. 2021. PMID: 33853611 Free PMC article.
-
LncRNAs in the Regulation of Genes and Signaling Pathways through miRNA-Mediated and Other Mechanisms in Clear Cell Renal Cell Carcinoma.Int J Mol Sci. 2021 Oct 17;22(20):11193. doi: 10.3390/ijms222011193. Int J Mol Sci. 2021. PMID: 34681854 Free PMC article. Review.
-
Long non-coding RNAs regulating macrophage functions in homeostasis and disease.Vascul Pharmacol. 2019 Mar;114:122-130. doi: 10.1016/j.vph.2018.02.011. Epub 2018 Mar 13. Vascul Pharmacol. 2019. PMID: 29548902 Free PMC article. Review.
-
The Hypoxia-Long Noncoding RNA Interaction in Solid Cancers.Int J Mol Sci. 2021 Jul 6;22(14):7261. doi: 10.3390/ijms22147261. Int J Mol Sci. 2021. PMID: 34298879 Free PMC article. Review.
-
A Signature of Five Long Non-Coding RNAs for Predicting the Prognosis of Alzheimer's Disease Based on Competing Endogenous RNA Networks.Front Aging Neurosci. 2021 Jan 28;12:598606. doi: 10.3389/fnagi.2020.598606. eCollection 2020. Front Aging Neurosci. 2021. PMID: 33584243 Free PMC article.
References
-
- Znaor A, Lortet-Tieulent J, Laversanne M, Jemal A, Bray F. International variations and trends in renal cell carcinoma incidence and mortality. Eur Urol 2015; 67: 519–530. - PubMed
-
- Ljungberg B, Campbell SC, Choi HY, Jacqmin D, Lee JE, Weikert S et al. The epidemiology of renal cell carcinoma. Eur Urol 2011; 60: 615–621. - PubMed
-
- Glen H. Lenvatinib therapy for the treatment of patients with advanced renal cell carcinoma. Future Oncol 2016; 12: 2195–2204. - PubMed
-
- Qu L, Ding J, Chen C, Wu ZJ, Liu B, Gao Y et al. Exosome-transmitted lncARSR promotes sunitinib resistance in renal cancer by acting as a competing endogenous RNA. Cancer Cell 2016; 29: 653–668. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous